Back to CELG-RI
STATE STREET CORP CELG-RI Position History
Bristol-Myers Squibb Company Ce
Quarters held
12
Latest value
$5.9B
Q2 2026
Peak value
$6B
First seen
Q4 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2023 | $4.6B |
| Q1 2024 | $5B |
| Q2 2024 | $3.8B |
| Q3 2024 | $4.8B |
| Q4 2024 | $5.4B |
| Q1 2025 | $5.8B |
| Q2 2025 | $4.4B |
| Q3 2025 | $4.4B |
| Q4 2025 | $5.3B |
| Q1 2026 | $6B |
| Q2 2026 | $5.9B |
| Q2 2026 | $5.9B |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $5.9B | 102.41M | — | — |
| Q2 2026 | $5.9B | 102.41M | — | — |
| Q1 2026 | $6B | 98.56M | — | — |
| Q4 2025 | $5.3B | 97.98M | — | — |
| Q3 2025 | $4.4B | 96.60M | — | — |
| Q2 2025 | $4.4B | 94.74M | — | — |
| Q1 2025 | $5.8B | 94.83M | — | — |
| Q4 2024 | $5.4B | 95.14M | — | — |
| Q3 2024 | $4.8B | 92.90M | — | — |
| Q2 2024 | $3.8B | 91.45M | — | — |
| Q1 2024 | $5B | 91.57M | — | — |
| Q4 2023 | $4.6B | 89.45M | — | — |